We use cookies to improve your experience and for marketing. Read our cookie policy or manage cookies.

Accept essential cookies
Accept all cookies
Report EU - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights for 499$
Report Update Nov 1, 2024

EU - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights

Single report
Sent by email within 24h (Mon-Fri)
What's the difference?
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

EU: Medicaments Containing Insulin Market 2024

Medicaments Containing Insulin Market Size in the EU

In 2021, after two years of growth, there was significant decline in the EU medicaments containing insulin market, when its value decreased by -40.1% to $X. Overall, consumption continues to indicate a abrupt decrease. Over the period under review, the market hit record highs at $X in 2012; however, from 2013 to 2021, consumption failed to regain momentum.

Medicaments Containing Insulin Production in the EU

In value terms, medicaments containing insulin production skyrocketed to $X in 2021 estimated in export price. In general, production showed a relatively flat trend pattern. The pace of growth appeared the most rapid in 2016 when the production volume increased by 21% against the previous year. The level of production peaked at $X in 2017; however, from 2018 to 2021, production stood at a somewhat lower figure.

Medicaments Containing Insulin Exports

Exports in the EU

In 2021, the amount of medicaments containing insulin but not antibiotics exported in the European Union soared to X tons, picking up by 43% compared with the previous year. In general, exports, however, showed a abrupt slump. The pace of growth appeared the most rapid in 2014 when exports increased by 47% against the previous year. The volume of export peaked at X tons in 2017; however, from 2018 to 2021, the exports remained at a lower figure.

In value terms, medicaments containing insulin exports surged to $X in 2021. Overall, exports, however, faced a abrupt downturn. The level of export peaked at $X in 2017; however, from 2018 to 2021, the exports failed to regain momentum.

Exports by Country

Austria (X tons) and Belgium (X tons) were the largest exporters of medicaments containing insulin but not antibiotics in 2021, recording near 41% and 32% of total exports, respectively. It was distantly followed by Denmark (X tons), creating a 14% share of total exports. The Czech Republic (X tons), Slovakia (X tons), Ireland (X tons) and France (X tons) held a relatively small share of total exports.

From 2012 to 2021, the biggest increases were recorded for Ireland (with a CAGR of +135.0%), while shipments for the other leaders experienced more modest paces of growth.

In value terms, the largest medicaments containing insulin supplying countries in the European Union were Austria ($X), Belgium ($X) and the Czech Republic ($X), together accounting for 81% of total exports. France, Denmark, Slovakia and Ireland lagged somewhat behind, together accounting for a further 10%.

Ireland, with a CAGR of +138.5%, recorded the highest growth rate of the value of exports, in terms of the main exporting countries over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

The export price in the European Union stood at $X per ton in 2021, growing by 42% against the previous year. Overall, the export price, however, continues to indicate a relatively flat trend pattern. The most prominent rate of growth was recorded in 2016 an increase of 78%. As a result, the export price reached the peak level of $X per ton. From 2017 to 2021, the export prices remained at a somewhat lower figure.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was the Czech Republic ($X per ton), while Denmark ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Austria (+13.9%), while the other leaders experienced more modest paces of growth.

Medicaments Containing Insulin Imports

Imports in the EU

In 2021, purchases abroad of medicaments containing insulin but not antibiotics decreased by -60.6% to X tons for the first time since 2018, thus ending a two-year rising trend. Overall, imports faced a abrupt setback. The pace of growth was the most pronounced in 2020 when imports increased by 582% against the previous year. Over the period under review, imports reached the peak figure at X tons in 2012; however, from 2013 to 2021, imports remained at a lower figure.

In value terms, medicaments containing insulin imports contracted notably to $X in 2021. Over the period under review, imports, however, continue to indicate a buoyant increase. The pace of growth was the most pronounced in 2020 when imports increased by 533%. As a result, imports reached the peak of $X, and then plummeted in the following year.

Imports by Country

The countries with the highest levels of medicaments containing insulin imports in 2021 were Denmark (X tons), together accounting for 98% of total import.

Denmark was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics imports, with a CAGR of +27.5% from 2012 to 2021. While the share of Denmark (+97 p.p.) increased significantly, the shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Denmark ($X) constitutes the largest market for imported medicaments containing insulin but not antibiotics in the European Union.

From 2012 to 2021, the average annual growth rate of value in Denmark totaled +20.7%.

Import Prices by Country

In 2021, the import price in the European Union amounted to $X per ton, surging by 114% against the previous year. Over the period under review, the import price recorded a significant increase. The pace of growth appeared the most rapid in 2013 an increase of 186%. The level of import peaked in 2021 and is expected to retain growth in the immediate term.

As there is only one major supplying country, the average price level is determined by prices for Denmark.

From 2012 to 2021, the rate of growth in terms of prices for Denmark amounted to -5.3% per year.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

Denmark constituted the country with the largest volume of medicaments containing insulin consumption, comprising approx. 91% of total volume. Moreover, medicaments containing insulin consumption in Denmark exceeded the figures recorded by the second-largest consumer, Spain, more than tenfold.
The countries with the highest volumes of medicaments containing insulin production in 2020 were Denmark, Spain and France, with a combined 84% share of total production. These countries were followed by Slovakia, Austria, Italy and Poland, which together accounted for a further 12%.
In value terms, France, the Czech Republic and Denmark constituted the countries with the highest levels of exports in 2020, together accounting for 83% of total exports. These countries were followed by Italy, Austria, the Netherlands and Slovakia, which together accounted for a further 12%.
In value terms, Denmark constitutes the largest market for imported medicaments containing insulin but not antibiotics in the European Union.
The medicaments containing insulin export price in the European Union stood at $101,180 per ton in 2020, surging by 219% against the previous year.
The medicaments containing insulin import price in the European Union stood at $44,033 per ton in 2020, reducing by -50.1% against the previous year.

This report provides an in-depth analysis of the medicaments containing insulin market in the EU. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale

Country coverage:

Data coverage:

  • Market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Production in the EU, split by region and country
  • Trade (exports and imports) in the EU
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS

  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO

  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and Its Prospects

    1. MARKET SIZE
    2. CONSUMPTION BY COUNTRY
    3. MARKET FORECAST TO 2030

  4. 4. MOST PROMISING PRODUCT

    Finding New Products to Diversify Your Business

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCT
    4. MOST TRADED PRODUCT
    5. MOST PROFITABLE PRODUCT FOR EXPORT

  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES

  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Exports

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS

  7. 7. PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE
    2. PRODUCTION BY COUNTRY

  8. 8. IMPORTS

    The Largest Importers on The Market and How They Succeed

    1. IMPORTS FROM 2012–2023
    2. IMPORTS BY COUNTRY
    3. IMPORT PRICES BY COUNTRY

  9. 9. EXPORTS

    The Largest Exporters on The Market and How They Succeed

    1. EXPORTS FROM 2012–2023
    2. EXPORTS BY COUNTRY
    3. EXPORT PRICES BY COUNTRY

  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

    This Chapter is Available Only for the Professional Edition PRO

  11. 11. COUNTRY PROFILES

    The Largest Markets And Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
    • Austria
    • Belgium
    • Bulgaria
    • Croatia
    • Cyprus
    • Czech Republic
    • Denmark
    • Estonia
    • Finland
    • France
    • Germany
    • Greece
    • Hungary
    • Ireland
    • Italy
    • Latvia
    • Lithuania
    • Luxembourg
    • Malta
    • Netherlands
    • Poland
    • Portugal
    • Romania
    • Slovakia
    • Slovenia
    • Spain
    • Sweden

  12. LIST OF TABLES

    1. Key Findings In 2023
    2. Market Volume, In Physical Terms, 2012–2023
    3. Market Value, 2012–2023
    4. Per Capita Consumption, By Country, 2018–2023
    5. Production, In Physical Terms, By Country, 2012–2023
    6. Imports, In Physical Terms, By Country, 2012–2023
    7. Imports, In Value Terms, By Country, 2012–2023
    8. Import Prices, By Country Of Destination, 2012–2023
    9. Exports, In Physical Terms, By Country, 2012–2023
    10. Exports, In Value Terms, By Country, 2012–2023
    11. Export Prices, By Country Of Origin, 2012–2023

  13. LIST OF FIGURES

    1. Market Volume, In Physical Terms, 2012–2023
    2. Market Value, 2012–2023
    3. Consumption, By Country, 2023
    4. Market Volume Forecast to 2030
    5. Market Value Forecast to 2030
    6. Products: Market Size And Growth, By Type
    7. Products: Average Per Capita Consumption, By Type
    8. Products: Exports And Growth, By Type
    9. Products: Export Prices And Growth, By Type
    10. Production Volume And Growth
    11. Exports And Growth
    12. Export Prices And Growth
    13. Market Size And Growth
    14. Per Capita Consumption
    15. Imports And Growth
    16. Import Prices
    17. Production, In Physical Terms, 2012–2023
    18. Production, In Value Terms, 2012–2023
    19. Production, By Country, 2023
    20. Production, In Physical Terms, By Country, 2012–2023
    21. Imports, In Physical Terms, 2012–2023
    22. Imports, In Value Terms, 2012–2023
    23. Imports, In Physical Terms, By Country, 2023
    24. Imports, In Physical Terms, By Country, 2012–2023
    25. Imports, In Value Terms, By Country, 2012–2023
    26. Import Prices, By Country, 2012–2023
    27. Exports, In Physical Terms, 2012–2023
    28. Exports, In Value Terms, 2012–2023
    29. Exports, In Physical Terms, By Country, 2023
    30. Exports, In Physical Terms, By Country, 2012–2023
    31. Exports, In Value Terms, By Country, 2012–2023
    32. Export Prices, 2012–2023

Recommended reports

Asia - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 354

This report provides an in-depth analysis of the medicaments containing insulin market in Asia.

World - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 356

This report provides an in-depth analysis of the global medicaments containing insulin market.

U.S. - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 297

This report provides an in-depth analysis of the medicaments containing insulin market in the U.S..

China - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 248

This report provides an in-depth analysis of the medicaments containing insulin market in China.

Free Data: Medicaments Containing Insulin But Not Antibiotics - European Union
Table
Medicaments Containing Insulin But Not Antibiotics - European Union - Table
Dashboard
Medicaments Containing Insulin But Not Antibiotics - European Union - Dashboard
Report
Medicaments Containing Insulin But Not Antibiotics - European Union - Report